Adult Day Services With Specialized Care Have Higher Proportion With Dementia
By Elana Gotkine HealthDay Reporter
THURSDAY, Jan. 25, 2024 -- Adult day services centers (ADSCs) that provide specialized dementia care have a higher proportion of patients with dementia compared with ADSCs that do not provide specialized care, according to a study published online Jan. 25 in National Health Statistics Reports, a publication from the U.S. Centers for Disease Control and Prevention.
Priyanka Singh, M.P.H., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues used data from the ADSC component of the 2020 National Post-acute and Long-term Care Study to compare the prevalence of Alzheimer disease or other dementias in ADSCs that provide specialized care for dementia to the prevalence in other ADSCs. Data were obtained from ADSCs in all 50 states and the District of Columbia.
The researchers found that 42.2 and 22.7 percent of participants had dementia in ADSCs that provide specialized dementia care and other ADSCs that do not specialize in dementia care, respectively. Across regions, the prevalence of dementia was similar, with a slightly lower percentage seen in the West. The prevalence of dementia was higher in ADSCs in metropolitan statistical areas, nonchain centers, and nonprofit centers.
"Findings from this report may inform providers, policy makers, researchers, and consumer advocates about the prevalence of dementia in ADSCs in general and in ADSCs that provide specialized care and ADSCs that do not provide specialized care for dementia," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-26 00:15
Read more
- ACAAI: 2013 to 2023 Saw Rise in Pediatric Psych Referrals Tied to Food Allergies
- Causal Relationship Seen Between GERD and Hypertension
- Quitting Smoking After Cancer Diagnosis Boosts Survival by Up to 26%
- Heat Waves Linked to Adverse Health Outcomes for Seniors
- Patient-Reported Lumbar Symptom Information Beneficial for Radiologists
- Study Characterizes Pediatric Patients Self-Presenting With Major Trauma
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions